Eterna Therapeutics Inc. Annual Revenues in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Eterna Therapeutics Inc. quarterly/annual Revenues history and growth rate from 2013 to 2023.
  • Eterna Therapeutics Inc. Revenues for the quarter ending September 30, 2024 was $487K, a 855% increase year-over-year.
  • Eterna Therapeutics Inc. annual Revenues for 2023 was $68K.
  • Eterna Therapeutics Inc. annual Revenues for 2022 was $0.000.
  • Eterna Therapeutics Inc. annual Revenues for 2020 was $5.8M, a 70.7% decline from 2019.
Revenues, Trailing 12 Months (USD)
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $68K +$68K Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $0 Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2020 $5.8M -$14M -70.7% Jan 1, 2020 Dec 31, 2020 10-K 2021-03-11
2019 $19.8M -$3.53M -15.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 $23.3M +$2.06M +9.69% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-19
2017 $21.3M -$1.04M -4.65% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-22
2016 $22.3M -$2.21M -9% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-09
2015 $24.5M -$1.53M -5.86% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-09
2014 $26M +$2.3M +9.67% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-15
2013 $23.7M Jan 1, 2013 Dec 31, 2013 10-K 2015-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.